Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Decision Support Among Surrogate Decision Makers of the Chronically Critically Ill (INVOLVE) (INVOLVE)

15. desember 2021 oppdatert av: Ronald Hickman, Case Western Reserve University

A Clinical Trial of Decision Support for End of Life Care Among Surrogate Decision Makers of the Chronically Critically Ill

Each year, millions of Americans are admitted to an intensive care unit (ICU). For more than half of them, ICU admission initiates a cascade of decisions about treatment and end-of-life care.This is particularly the case for patients with chronic critical illness, a life-limiting syndrome. Most (74%-82%) ICU patients who require mechanical ventilation have transient or persistent cognitive impairment that precludes them from making their own healthcare decisions. Among ICU patients, the chronically critically ill (CCI) are at highest risk for cognitive impairment and thus require a surrogate decision maker (SDM), usually a family member. SDMs for the critically ill often describe high states of psychological stress associated with the uncertainty of the patient's condition and their decision making role.

The purpose of this study is to test the effectiveness of two decision support interventions for end-of-life care delivered to SDMs of CCI patients. This will be the first study to test interventions tailored to the unique needs of the SDMs of CCI patients delivered using an interactive avatar based format.

Studieoversikt

Detaljert beskrivelse

The investigators will conduct a three-arm unblinded clinical trial using pre- and post-tests to evaluate the efficacy of two electronic decision-support interventions, Interactive Virtual Decision Support for End-of-Life and Palliative Care (INVOLVE) and Informational Support (IS), compared to each other and to usual care (UC) among 270 SDMs of cognitively impaired CCI patients. This design will allow the investigators to prospectively compare the efficacy of the experiential avatar-based decision support tool (INVOLVE) with both an information-only condition and UC. Subjects assigned to an experimental condition (INVOLVE or IS) will receive two doses of the intervention, at enrollment and 1 day later. After the second dose, these subjects will have access to their assigned condition for subsequent self-administered doses, which will be electronically captured until the patient's ICU discharge or death. Data will be collected at (T1) baseline (Day 3 or 4 of the patient's ICU stay), and then on Days 1, 3, 7 and 90 post-baseline

.

The investigators aim to:

  1. Identify the essential elements of the graphical user interface and educational content needed to revise the INVOLVE prototype for a set of common end-of-life decisions that occur in the ICU.
  2. Evaluate if there are differences in the decision making readiness and decision making quality between subjects exposed to INVOLVE, IS, or UC on Days 1, 3, and 7 days post-baseline while accounting for covariates (prior SDM experience, SDM knowledge of the patient's preferences, and SDM's religious beliefs).
  3. Determine if there are differences in the post-decision outcomes of SDMs and their CCI patient by study condition while accounting for covariates at 90 days post-baseline.

Studietype

Intervensjonell

Registrering (Faktiske)

281

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Ohio
      • Cleveland, Ohio, Forente stater, 44106
        • University Hospitals Case Medical Center

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Eligibility criteria for CCI patients:

  • aged 18 years or older
  • required mechanical ventilation and ICU stay for greater than or equal to 3 days
  • not expected to be transferred out of the ICU within 48 hours
  • lacks cognitive capacity, as determined by a Glasgow Coma Scale eye score of less than 3 or the motor score less than 6 and verifying the status by asking the patients's attending physician or advanced practice nurse whether he or she would obtain consent from the patient or a family member
  • has an identified SDM (next-of-kin or legal representative for healthcare decision making).

Eligibility criteria for SDMs:

  • aged 18 years or older
  • identified by the healthcare team as the patient's next of kin or legal representative for healthcare decision making
  • able to speak and understand English
  • able to view images on an 10-inch computer screen and hear audio through a standard set of headphones.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Støttende omsorg
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: INVOLVE
The first study condition, called "Interactive Virtual Decision Support for End-of-Life and Palliative Care (INVOLVE)" will consist of exposures to an avatar-based decision support technology that will be administered via tablet computer and allow SDMs opportunities to practice their communication and decision making skills through interactions with avatars that portray a decision coach and various healthcare providers.
Interactive content and decision coaching with tailored framing of messages to subject's informational processing style and stage of change to promote participatory decision making behavior. Consideration of options, consequences, values, and preferences to formulate an informed decision.
Eksperimentell: Informational Support
The second condition, called Informational Support (IS), will also be administered via tablet computers and expose SDMs to educational resources of INVOLVE without the experiential components.
Passive, non-tailored informational support. Screen-based education (videos) with information content on advance care decisions that occur in the intensive care unit.
Eksperimentell: Usual Care
The third condition, usual care (UC), will expose SDMs to the routine communication and decisional support practices provided by the healthcare team.
Routine decision support practices by the healthcare team. Family meetings, bedside updates, and access to printed or electronic decision aids.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Repeated Measures
Tidsramme: From (T1) baseline through (T5) 90 days post-baseline
ANOVA Model (F-Statistic)
From (T1) baseline through (T5) 90 days post-baseline

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Preparation for Decision Making Scale
Tidsramme: (T1) baseline through (T4) 7 days post-baseline
Measure of Decision Making Preparedness
(T1) baseline through (T4) 7 days post-baseline
Change in Family Decision Making Self-Efficacy Scale
Tidsramme: (T1) baseline through (T4) 7 days post-baseline
Measure of Decision Making Self-Efficacy
(T1) baseline through (T4) 7 days post-baseline
Change in Single item measure of Role Stress
Tidsramme: (T1) baseline through (T4) 7 days post-baseline
Measure of Decisional Role Stress
(T1) baseline through (T4) 7 days post-baseline
Change in Decision Conflict Scale
Tidsramme: (T1) baseline through (T4) 7 days post-baseline
Measure of Decision Conflict
(T1) baseline through (T4) 7 days post-baseline
Change in Modified Control Preferences Scale
Tidsramme: (T1) baseline through (T4) 7 days post-baseline
Measure of Behavioral Activation
(T1) baseline through (T4) 7 days post-baseline
Change in Decision Regret Scale
Tidsramme: (T1) baseline and (T5) 90 days post-baseline
Measure of Decision Regret
(T1) baseline and (T5) 90 days post-baseline
Change in Hospital Anxiety and Depression Scale
Tidsramme: (T1) baseline and (T5) 90 days post-baseline
Measure of Anxiety and Depressive Symptoms
(T1) baseline and (T5) 90 days post-baseline

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. september 2015

Primær fullføring (Faktiske)

1. juni 2020

Studiet fullført (Faktiske)

1. juni 2020

Datoer for studieregistrering

Først innsendt

22. februar 2017

Først innsendt som oppfylte QC-kriteriene

28. mars 2017

Først lagt ut (Faktiske)

4. april 2017

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. desember 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

15. desember 2021

Sist bekreftet

1. desember 2021

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • 08-16-25
  • 5R01NR015750-02 (U.S. NIH-stipend/kontrakt)

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Kritisk sykdom

Abonnere